APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Endocrine Testing Service Market Analysis and Forecast 2026-2032

1 January 2026206 pages

Choose your research edition.

Industry ResearchEndocrine Testing Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Testing Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Endocrine Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Testing Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Testing Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Endocrine Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Endocrine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Endocrine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Endocrine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Endocrine Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Endocrine Testing Service include Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A. and Immunodiagnostic Systems, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Endocrine Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Endocrine Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Endocrine Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Endocrine Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Endocrine Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Endocrine Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Endocrine Testing Service Segment by Company

Hoffmann-La Roche Ltd.

Abbott Laboratories

Agilent Technologies

BioMerieux S.A.

Bio-Rad Laboratories, Inc.

Siemens Healthineers

Danaher Corporation

DiaSorin S.p.A.

Immunodiagnostic Systems

Laboratory Corporation of America Holdings

Fujirebio, Inc.

Thermo Fisher Scientific Inc.

Quest Diagnostics

Sysmex Corporation

MP Biomedicals

Ortho Clinical Diagnostics

Meridian Life Science, Inc.

Endocrine Testing Service Segment by Type

Prolactin Testing

Progesterone Testing

Testosterone Testing

Endocrine Testing Service Segment by Application

Hospitals

Clinics

Endocrine Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Endocrine Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Endocrine Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Endocrine Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prolactin Testing Major Player Table 3. Progesterone Testing Major Player Table 4. Testosterone Testing Major Player Table 5. Global Endocrine Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Clinics Major Player Table 8. Endocrine Testing Service Industry Trends Table 9. Endocrine Testing Service Industry Drivers Table 10. Endocrine Testing Service Industry Opportunities and Challenges Table 11. Endocrine Testing Service Industry Restraints Table 12. Global Endocrine Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Endocrine Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Endocrine Testing Service Market Share by Region (2021-2026) Table 15. Global Endocrine Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Endocrine Testing Service Market Share by Region (2027-2032) Table 17. Global Endocrine Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Endocrine Testing Service Revenue Market Share by Players (2021-2026) Table 19. Global Endocrine Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Endocrine Testing Service Key Players Headquarters & Area Served Table 21. Global Endocrine Testing Service Players, Product Type & Application Table 22. Global Endocrine Testing Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Endocrine Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Endocrine Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Endocrine Testing Service Revenue Market Share by Type (2021-2026) Table 29. Global Endocrine Testing Service Revenue Market Share by Type (2027-2032) Table 30. Global Endocrine Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Endocrine Testing Service Revenue Market Share by Application (2021-2026) Table 34. Global Endocrine Testing Service Revenue Market Share by Application (2027-2032) Table 35. Hoffmann-La Roche Ltd. Company Information Table 36. Hoffmann-La Roche Ltd. Business Overview Table 37. Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio Table 39. Hoffmann-La Roche Ltd. Recent Development Table 40. Abbott Laboratories Company Information Table 41. Abbott Laboratories Business Overview Table 42. Abbott Laboratories Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Laboratories Endocrine Testing Service Product Portfolio Table 44. Abbott Laboratories Recent Development Table 45. Agilent Technologies Company Information Table 46. Agilent Technologies Business Overview Table 47. Agilent Technologies Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Agilent Technologies Endocrine Testing Service Product Portfolio Table 49. Agilent Technologies Recent Development Table 50. BioMerieux S.A. Company Information Table 51. BioMerieux S.A. Business Overview Table 52. BioMerieux S.A. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BioMerieux S.A. Endocrine Testing Service Product Portfolio Table 54. BioMerieux S.A. Recent Development Table 55. Bio-Rad Laboratories, Inc. Company Information Table 56. Bio-Rad Laboratories, Inc. Business Overview Table 57. Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio Table 59. Bio-Rad Laboratories, Inc. Recent Development Table 60. Siemens Healthineers Company Information Table 61. Siemens Healthineers Business Overview Table 62. Siemens Healthineers Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Siemens Healthineers Endocrine Testing Service Product Portfolio Table 64. Siemens Healthineers Recent Development Table 65. Danaher Corporation Company Information Table 66. Danaher Corporation Business Overview Table 67. Danaher Corporation Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Danaher Corporation Endocrine Testing Service Product Portfolio Table 69. Danaher Corporation Recent Development Table 70. DiaSorin S.p.A. Company Information Table 71. DiaSorin S.p.A. Business Overview Table 72. DiaSorin S.p.A. Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. DiaSorin S.p.A. Endocrine Testing Service Product Portfolio Table 74. DiaSorin S.p.A. Recent Development Table 75. Immunodiagnostic Systems Company Information Table 76. Immunodiagnostic Systems Business Overview Table 77. Immunodiagnostic Systems Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Immunodiagnostic Systems Endocrine Testing Service Product Portfolio Table 79. Immunodiagnostic Systems Recent Development Table 80. Laboratory Corporation of America Holdings Company Information Table 81. Laboratory Corporation of America Holdings Business Overview Table 82. Laboratory Corporation of America Holdings Endocrine Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio Table 84. Laboratory Corporation of America Holdings Recent Development Table 85. Fujirebio, Inc. Company Information Table 86. Fujirebio, Inc. Business Overview Table 87. Fujirebio, Inc. Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Fujirebio, Inc. Endocrine Testing Service Product Portfolio Table 89. Fujirebio, Inc. Recent Development Table 90. Thermo Fisher Scientific Inc. Company Information Table 91. Thermo Fisher Scientific Inc. Business Overview Table 92. Thermo Fisher Scientific Inc. Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio Table 94. Thermo Fisher Scientific Inc. Recent Development Table 95. Quest Diagnostics Company Information Table 96. Quest Diagnostics Business Overview Table 97. Quest Diagnostics Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Quest Diagnostics Endocrine Testing Service Product Portfolio Table 99. Quest Diagnostics Recent Development Table 100. Sysmex Corporation Company Information Table 101. Sysmex Corporation Business Overview Table 102. Sysmex Corporation Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sysmex Corporation Endocrine Testing Service Product Portfolio Table 104. Sysmex Corporation Recent Development Table 105. MP Biomedicals Company Information Table 106. MP Biomedicals Business Overview Table 107. MP Biomedicals Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. MP Biomedicals Endocrine Testing Service Product Portfolio Table 109. MP Biomedicals Recent Development Table 110. Ortho Clinical Diagnostics Company Information Table 111. Ortho Clinical Diagnostics Business Overview Table 112. Ortho Clinical Diagnostics Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio Table 114. Ortho Clinical Diagnostics Recent Development Table 115. Meridian Life Science, Inc. Company Information Table 116. Meridian Life Science, Inc. Business Overview Table 117. Meridian Life Science, Inc. Endocrine Testing Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio Table 119. Meridian Life Science, Inc. Recent Development Table 120. North America Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Endocrine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Endocrine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Endocrine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Endocrine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 134. China Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 135. China Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 136. China Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 137. China Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Endocrine Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Endocrine Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Endocrine Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Endocrine Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Endocrine Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Endocrine Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Endocrine Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Endocrine Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Endocrine Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Endocrine Testing Service Image Figure 2. Global Endocrine Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prolactin Testing Image Figure 5. Progesterone Testing Image Figure 6. Testosterone Testing Image Figure 7. Global Endocrine Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Endocrine Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Global Endocrine Testing Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Endocrine Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Endocrine Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Endocrine Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Endocrine Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Endocrine Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Endocrine Testing Service Revenue Market Share by Type (2021-2032) Figure 19. Global Endocrine Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Endocrine Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Endocrine Testing Service Revenue Market Share by Application (2021-2032) Figure 22. North America Endocrine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Endocrine Testing Service Revenue Share by Type (2021-2032) Figure 24. North America Endocrine Testing Service Revenue Share by Application (2021-2032) Figure 25. North America Endocrine Testing Service Revenue Share by Country (2021-2032) Figure 26. United States Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Endocrine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Endocrine Testing Service Revenue Share by Type (2021-2032) Figure 31. Europe Endocrine Testing Service Revenue Share by Application (2021-2032) Figure 32. Europe Endocrine Testing Service Revenue Share by Country (2021-2032) Figure 33. Germany Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Endocrine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Endocrine Testing Service Revenue Share by Type (2021-2032) Figure 43. China Endocrine Testing Service Revenue Share by Application (2021-2032) Figure 44. Asia Endocrine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Endocrine Testing Service Revenue Share by Type (2021-2032) Figure 46. Asia Endocrine Testing Service Revenue Share by Application (2021-2032) Figure 47. Asia Endocrine Testing Service Revenue Share by Region (2021-2032) Figure 48. Japan Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Endocrine Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Endocrine Testing Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Endocrine Testing Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Endocrine Testing Service Revenue Share by Country (2021-2032) Figure 58. Brazil Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Endocrine Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Prolactin Testing
  • Progesterone Testing
  • Testosterone Testing
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Agilent Technologies
  • BioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Immunodiagnostic Systems
  • Laboratory Corporation of America Holdings
  • Fujirebio, Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics
  • Sysmex Corporation
  • MP Biomedicals
  • Ortho Clinical Diagnostics
  • Meridian Life Science, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Endocrine Testing Service Market by Type
  3. 1.2.1 Global Endocrine Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prolactin Testing
  5. 1.2.3 Progesterone Testing
  6. 1.2.4 Testosterone Testing
  7. 1.3 Endocrine Testing Service Market by Application
  8. 1.3.1 Global Endocrine Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Endocrine Testing Service Market Dynamics
  1. 2.1 Endocrine Testing Service Industry Trends
  2. 2.2 Endocrine Testing Service Industry Drivers
  3. 2.3 Endocrine Testing Service Industry Opportunities and Challenges
  4. 2.4 Endocrine Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Endocrine Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Endocrine Testing Service Growth Trends by Region
  3. 3.2.1 Global Endocrine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Endocrine Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Endocrine Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Endocrine Testing Service Revenue by Players
  2. 4.1.1 Global Endocrine Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Endocrine Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Endocrine Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Endocrine Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Endocrine Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Endocrine Testing Service Players, Product Type & Application
  8. 4.5 Global Endocrine Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Endocrine Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Endocrine Testing Service Tier 1, Tier 2, and Tier 3
5 Endocrine Testing Service Market Size by Type
  1. 5.1 Global Endocrine Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Endocrine Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Endocrine Testing Service Revenue Market Share by Type (2021-2032)
6 Endocrine Testing Service Market Size by Application
  1. 6.1 Global Endocrine Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Endocrine Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Endocrine Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hoffmann-La Roche Ltd.
  2. 7.1.1 Hoffmann-La Roche Ltd. Company Information
  3. 7.1.2 Hoffmann-La Roche Ltd. Business Overview
  4. 7.1.3 Hoffmann-La Roche Ltd. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hoffmann-La Roche Ltd. Endocrine Testing Service Product Portfolio
  6. 7.1.5 Hoffmann-La Roche Ltd. Recent Developments
  7. 7.2 Abbott Laboratories
  8. 7.2.1 Abbott Laboratories Company Information
  9. 7.2.2 Abbott Laboratories Business Overview
  10. 7.2.3 Abbott Laboratories Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Laboratories Endocrine Testing Service Product Portfolio
  12. 7.2.5 Abbott Laboratories Recent Developments
  13. 7.3 Agilent Technologies
  14. 7.3.1 Agilent Technologies Company Information
  15. 7.3.2 Agilent Technologies Business Overview
  16. 7.3.3 Agilent Technologies Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Endocrine Testing Service Product Portfolio
  18. 7.3.5 Agilent Technologies Recent Developments
  19. 7.4 BioMerieux S.A.
  20. 7.4.1 BioMerieux S.A. Company Information
  21. 7.4.2 BioMerieux S.A. Business Overview
  22. 7.4.3 BioMerieux S.A. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BioMerieux S.A. Endocrine Testing Service Product Portfolio
  24. 7.4.5 BioMerieux S.A. Recent Developments
  25. 7.5 Bio-Rad Laboratories, Inc.
  26. 7.5.1 Bio-Rad Laboratories, Inc. Company Information
  27. 7.5.2 Bio-Rad Laboratories, Inc. Business Overview
  28. 7.5.3 Bio-Rad Laboratories, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Rad Laboratories, Inc. Endocrine Testing Service Product Portfolio
  30. 7.5.5 Bio-Rad Laboratories, Inc. Recent Developments
  31. 7.6 Siemens Healthineers
  32. 7.6.1 Siemens Healthineers Company Information
  33. 7.6.2 Siemens Healthineers Business Overview
  34. 7.6.3 Siemens Healthineers Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Siemens Healthineers Endocrine Testing Service Product Portfolio
  36. 7.6.5 Siemens Healthineers Recent Developments
  37. 7.7 Danaher Corporation
  38. 7.7.1 Danaher Corporation Company Information
  39. 7.7.2 Danaher Corporation Business Overview
  40. 7.7.3 Danaher Corporation Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Danaher Corporation Endocrine Testing Service Product Portfolio
  42. 7.7.5 Danaher Corporation Recent Developments
  43. 7.8 DiaSorin S.p.A.
  44. 7.8.1 DiaSorin S.p.A. Company Information
  45. 7.8.2 DiaSorin S.p.A. Business Overview
  46. 7.8.3 DiaSorin S.p.A. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DiaSorin S.p.A. Endocrine Testing Service Product Portfolio
  48. 7.8.5 DiaSorin S.p.A. Recent Developments
  49. 7.9 Immunodiagnostic Systems
  50. 7.9.1 Immunodiagnostic Systems Company Information
  51. 7.9.2 Immunodiagnostic Systems Business Overview
  52. 7.9.3 Immunodiagnostic Systems Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Immunodiagnostic Systems Endocrine Testing Service Product Portfolio
  54. 7.9.5 Immunodiagnostic Systems Recent Developments
  55. 7.10 Laboratory Corporation of America Holdings
  56. 7.10.1 Laboratory Corporation of America Holdings Company Information
  57. 7.10.2 Laboratory Corporation of America Holdings Business Overview
  58. 7.10.3 Laboratory Corporation of America Holdings Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Laboratory Corporation of America Holdings Endocrine Testing Service Product Portfolio
  60. 7.10.5 Laboratory Corporation of America Holdings Recent Developments
  61. 7.11 Fujirebio, Inc.
  62. 7.11.1 Fujirebio, Inc. Company Information
  63. 7.11.2 Fujirebio, Inc. Business Overview
  64. 7.11.3 Fujirebio, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Fujirebio, Inc. Endocrine Testing Service Product Portfolio
  66. 7.11.5 Fujirebio, Inc. Recent Developments
  67. 7.12 Thermo Fisher Scientific Inc.
  68. 7.12.1 Thermo Fisher Scientific Inc. Company Information
  69. 7.12.2 Thermo Fisher Scientific Inc. Business Overview
  70. 7.12.3 Thermo Fisher Scientific Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific Inc. Endocrine Testing Service Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Inc. Recent Developments
  73. 7.13 Quest Diagnostics
  74. 7.13.1 Quest Diagnostics Company Information
  75. 7.13.2 Quest Diagnostics Business Overview
  76. 7.13.3 Quest Diagnostics Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Quest Diagnostics Endocrine Testing Service Product Portfolio
  78. 7.13.5 Quest Diagnostics Recent Developments
  79. 7.14 Sysmex Corporation
  80. 7.14.1 Sysmex Corporation Company Information
  81. 7.14.2 Sysmex Corporation Business Overview
  82. 7.14.3 Sysmex Corporation Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sysmex Corporation Endocrine Testing Service Product Portfolio
  84. 7.14.5 Sysmex Corporation Recent Developments
  85. 7.15 MP Biomedicals
  86. 7.15.1 MP Biomedicals Company Information
  87. 7.15.2 MP Biomedicals Business Overview
  88. 7.15.3 MP Biomedicals Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 MP Biomedicals Endocrine Testing Service Product Portfolio
  90. 7.15.5 MP Biomedicals Recent Developments
  91. 7.16 Ortho Clinical Diagnostics
  92. 7.16.1 Ortho Clinical Diagnostics Company Information
  93. 7.16.2 Ortho Clinical Diagnostics Business Overview
  94. 7.16.3 Ortho Clinical Diagnostics Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Ortho Clinical Diagnostics Endocrine Testing Service Product Portfolio
  96. 7.16.5 Ortho Clinical Diagnostics Recent Developments
  97. 7.17 Meridian Life Science, Inc.
  98. 7.17.1 Meridian Life Science, Inc. Company Information
  99. 7.17.2 Meridian Life Science, Inc. Business Overview
  100. 7.17.3 Meridian Life Science, Inc. Endocrine Testing Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Meridian Life Science, Inc. Endocrine Testing Service Product Portfolio
  102. 7.17.5 Meridian Life Science, Inc. Recent Developments
8 North America
  1. 8.1 North America Endocrine Testing Service Revenue (2021-2032)
  2. 8.2 North America Endocrine Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Endocrine Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Endocrine Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Endocrine Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Endocrine Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Endocrine Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Endocrine Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Endocrine Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Endocrine Testing Service Revenue by Country
  11. 8.6.1 North America Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Endocrine Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Endocrine Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Endocrine Testing Service Revenue (2021-2032)
  2. 9.2 Europe Endocrine Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Endocrine Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Endocrine Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Endocrine Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Endocrine Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Endocrine Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Endocrine Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Endocrine Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Endocrine Testing Service Revenue by Country
  11. 9.6.1 Europe Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Endocrine Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Endocrine Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Endocrine Testing Service Revenue (2021-2032)
  2. 10.2 China Endocrine Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Endocrine Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Endocrine Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Endocrine Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Endocrine Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Endocrine Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Endocrine Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Endocrine Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Endocrine Testing Service Revenue (2021-2032)
  2. 11.2 Asia Endocrine Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Endocrine Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Endocrine Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Endocrine Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Endocrine Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Endocrine Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Endocrine Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Endocrine Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Endocrine Testing Service Revenue by Country
  11. 11.6.1 Asia Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Endocrine Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Endocrine Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Endocrine Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Endocrine Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Endocrine Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Endocrine Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Endocrine Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Endocrine Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Endocrine Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Endocrine Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Endocrine Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Endocrine Testing Service Revenue by Country
  11. 12.6.1 SAMEA Endocrine Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Endocrine Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Endocrine Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst